Introduction
CD4+ T-cell depletion is the most important pathogenic feature of HIV-1 infection, caused by direct virus infection and bystander mechanisms of damage. Another relevant immunological dysfunction occurring during HIV-1 infection is the expansion of CD8+ T cells likely reflecting an altered homoeostasis of T lymphocytes; elevated CD8+ Tcell counts can be found in the blood of infected patients until the phase preceding AIDS when a generalized T-cell depletion takes place [1] . CD8+ T-cell expansion is not limited to HIV-1-specific CD8+ T cells but includes the whole bulk of CD8+ T cells, with a broad range of antigen specificities [2] . Antiretroviral therapy (ART), while resulting in the recovery of CD4+ T-cell counts, has a limited effect on the enlarged size of the CD8+ T-cell compartment [3] ; treatment initiated during primary HIV-1 infection may control expansion of CD8+ T cells, although very few studies have addressed this abnormality [4] . The increased number of CD8+ T cells in circulation, and the decreased CD4+ T-cell counts measured in HIV-1 infected patients, results in a low blood CD4+/CD8+ T-cell ratio, which is used in the clinic as a prognostic factor for disease progression [5] . The CD4+/CD8+ T-cell ratio can be regulated by multiple factors including the history of antigenic exposure of the individual, gender and age [6, 7] .
A low CD4+/CD8+ T-cell ratio during HIV-1 infection is associated with T-cell senescence and increased T-cell activation, as well as the appearance of non-AIDS-related diseases including cardiovascular diseases and tumours [8, 9] . The factors that influence the expansion of CD8+ T cells in HIV-1 infected patients, even after ART administration, remain to a large extent unknown.
Elucidation of the immunological mechanisms that influence the homoeostasis and expansion of CD8+ T cells during HIV-1 infection is of major importance to further dissect the molecular basis of HIV-1 pathogenesis, to prevent progressive loss of immune functions and occurrence of collateral diseases.
Alterations in the composition of CD8+ T-cell subsets during HIV-1 infection
Antigen encounter by T lymphocytes results in cell activation, proliferation and generation of effector T cells; at the end of this process, the majority of the antigen-specific effector cells are eliminated by apoptosis with a small pool of cells further differentiating into memory T cells [10] . Even though both CD4+ and CD8+ T cells pursue this pattern of differentiation into memory T cells, unique clues regulate the expansion of the two T-cell populations.
Na€ ıve CD8+ T cells initiate a proliferation programme in the presence of antigen; after antigen encounter, CD8+ T cells retain an activation status that enables them to proliferate autonomously, even in the absence of antigen, and to differentiate into CD8+ memory T cells [11, 12] . In support of these findings, the comparison of CD4+ and CD8+ T cell responses during Listeria monocytogenes infection, revealed that CD8+ T cells proliferated at higher rates compared to CD4+ T cells, indicating an intrinsic difference between the two T-cell types in response to antigenic stimuli [13] . Interestingly, the differentiation of naive CD8+ T cells into memory cells was found to be dependent on the number of cell divisions that the CD8+ T cells had undergone, with at least five divisions being necessary for the transition to a memory phenotype [14] . According to these findings, the strength and duration of antigenic exposure during HIV-1 infection appear to be major regulators of the development and maintenance of the CD8+ memory T-cell pool, including HIV-1-specific CD8+ T cells.
During HIV-1 infection an expansion of CD8+ T cells, primarily CDR45RO+ memory and effector CD8+ T cells take place in the lymph nodes (LNs); a larger number of memory and effector CD8+ T cells can be found in the blood of infected individuals [15] , accompanied by a reduction of naive CD8+ T cells in circulation [16] (Fig. 1) . In addition, CD8+ T-cell subsets from HIV-1-infected individuals display a higher activation status, as measured by the expression of activation markers [17] , a higher turnover compared to CD4+ T cells and shortened telomeres compared to controls [18, 19] .
A study evaluating proliferation of both CD4+ and CD8+ T cells in chronically HIV-1 infected individuals treated with ART, or na€ ıve to treatment, indicated that the frequency of proliferating na€ ıve CD8+ T cells is not regulated by the size of the CD8+ T-cell pool, as previously noticed for CD4+ T cells, but rather by other factors including virus replication and immune activation [20] . These data suggest that the unbalanced proliferation of CD8+ T cells occurring during HIV-1 infection may likely depend on both virus infection and endogenous CD8+ T-cell properties. It is therefore possible that HIV-1 infection may induce an activation status in CD8+ T cells of multiple specificities, including but not limited to EBV and CMV CD8+ T cells [21] that may persist even when virus replication is under control and result in excessive CD8+ T-cell proliferation and maintenance of an inverted CD4/CD8 T-cell ratio.
Peripheral expansion of CD8+ T cells, followed by terminal differentiation under constant antigenic and inflammatory pressure, are mechanisms likely contributing to CD8+ lymphocytosis. The main pathway for regeneration of mature T lymphocytes is through thymic development and selection; pathway independent of thymic function has, however, also been described, with special emphasis given to the extrathymic generation of CD8+ T cells [22] . During HIV-1 infection, the expansion of senescent CD28 -T cells has been reported [23] ; these cells constitute more than 50% of the circulating CD8+ T cells indicating that both HIV-1-specific and nonspecific CD8+ T cells are comprised within this population [24, 25] . A subset of CD8+CD28 -T cells composed of both memory and effector cells can also be found in circulation in other viral infections including EBV and CMV infections [26] [27] [28] . The characteristics of CD8+CD28À T cells, which originate from CD8+CD28+ T cells, are shorter telomeres compared to the CD28+ counterparts [29] , senescence features and impaired proliferative responses following antigen exposure [24, [30] [31] [32] .
trafficking and homing of different lymphocyte subsets to tissues where they exert their function. During HIV-1 infection, intensive viral replication occurs in LNs, and alterations in the homing capacities of CD8+ T cells may take place in order for these cells to reach infected, inflamed tissue to control the infection. These changes in CD8+ T-cell homing capacities can result in altered numbers of CD8+ T cells in circulation and tissues. Na€ ıve T cells home to the LNs guided by CCR7, whereas effector T cells exit the LNs and migrate towards the inflamed tissues responding to the chemokines receptors CXCR3 and CCR5 [33] .
HIV-1 infection leads to increased expression of specific chemokines in the LNs that, during the early stage of infection, results in the accumulation of CD8+ T cells in this tissue [34, 35] . During the chronic phase of the infection, chemokine expression in LNs declines, and homing of CD8+ T cells to the LNs is reduced [36] ; in addition, upon ART introduction, lymphocytes can egress from the LNs to the circulation accumulating in larger numbers in this compartment [37] .
The production of the chemokines CXCL9 and CXCL10 is induced in lymphoid tissues early during SIV infection of rhesus macaques, leading to the recruitment of CXCR3 expressing lymphocytes in these tissues [38] (Fig. 2) . The levels of CXCL9 and CXCL10 are also increased in the plasma of chronically HIV-1 infected individuals [39] . CXCR3 is a chemokine receptor, found on effector and recently activated lymphocytes in blood, which mediates the homing of CD8+ T cells to inflamed tissues of HIV-1-infected individuals [40] [41] [42] (Fig. 2) . During the asymptomatic phase of HIV-1 infection, increased frequencies of CXCR3+CD8+ T cells have been detected in both blood and the LNs [39] . CXCR3 expression is regulated by the level of antigenic stimulation, with short-term activation in vitro resulting in CXCR3 induction and long-term antigenic activation in CXCR3 downregulation [43, 44] . In addition to CXCR3, another chemokine receptor, CCR5, which is expressed on effector and memory CD8+ T cells, targets lymphocytes to the inflamed tissues to control infection [45, 46] (Fig. 2) . During primary HIV-1 infection, the expression of CCR5 on CD8+ blood T cells is increased, and CCR5+CD8+ T cells are proliferating at higher levels compared to cells from noninfected individuals [47] . The adhesive capacity of T lymphocytes in LNs of HIV-1-infected individuals is also increased, indicating that retention of these cells into the LN can also be mediated by the altered expression of adhesion molecules [15] . The changes in adhesion molecule expression were also evident amongst the CD8+CD28À expanded T-cell population of HIV-1-infected individuals which was negative for expression of the integrin CD11b resulting in impaired adhesion of CD8+CD28À T cells to endothelial cells [48] .
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In particular, altered trafficking of CD8+ T cells has been reported in the gastrointestinal (GI) tract mucosa and the gut-associated lymphoid tissue (GALT) where the initial foci of HIV-1 infection can be found. During acute SIV infection, antigenspecific CD8+ T cells expand in the GI mucosa in parallel with depletion of CD4+ T cells [49] . In addition, in the GI mucosa, CD8+ T cells are CCR5+ and ligands for CCR5 (RANTES, CCL3 and CCL4) are also highly expressed in this tissue [50] . The accumulation of CD8+ T cells in the mucosa of HIV-1-infected individuals can be partially explained by the fact that antigen-specific effector and memory CD45RO+CD8+ T cells primed in the secondary lymphoid tissues of the mucosa acquire the expression of molecules that enables them to home back to effector sites in this tissue after exit from this tissue and circulation in the blood [51, 52] . Interestingly, the majority of HIV-1 specific In the lymphoid tissues, intense immune activation due to virus replication leads to deposition of collagen and increased fibrosis which contributes to the altered homing of lymphocytes responding to increased production of cytokines and chemokines. IL-15, a cytokine produced at high levels during HIV-1 infection was shown to direct memory CD8+ T cells into the inflamed tissues. In addition, accumulation and increased proliferation of effector and memory CCR5+CD8+ T lymphocytes occur, with the capacity to migrate to inflamed tissues in response to CCR5+ attracting chemokines (RANTES, CCL3 and CCL4) which can be found at high concentration in the gut-associated lymphoid tissue (GALT). Increased levels of CXCL9 and CXCL10 have been reported to occur in infected patients; in response to these chemokines, activated CXCR3+CD8+ T cells migrate from blood into inflamed tissues, including the lungs and gut.
CTL clones are shared between peripheral blood PBMCs and the mucosal tissue indicating that the initial expansion of CD8+ T cells occurs at the mucosal sites [53] . Administration of ART during chronic HIV-1 infection led to reduced levels of CD8+ T cells in the GI [54] .
During HIV-1 infection, there is a decreased capacity of CD8+ T cells to localize in the GALT as CD8+ T cells express lower level of a 4 b 7 , one of the main integrins mediating lymphocyte homing to GALT by binding to MAdCAM1 expressing endothelial cells. Within the GALT, there is also a reduced expression of aEb7, another integrin-mediating retention of CD8+ T cells within this tissue through interaction with E-cadherin in epithelial cells [55] [56] [57] . A higher frequency of CD8+ T cells with the capacity to home to the GI has been identified in the blood of HIV-1-infected individuals; the frequency of guthoming CD8+ T cells is reduced in patients receiving ART [58] .
The distinct alteration in the expression of chemokines and chemokine receptors is not the only factor leading to perturbation of CD8+ T-cell homing during HIV-1 infection. Immune activation and inflammation, occurring already during early stage of the infection, are major causes for permanent pathophysiological changes in the lymphoid tissues characterized by increased fibrosis and collagen deposition. These alterations might also contribute to altered chemokine production and adhesion molecule expression by the lymphoid tissue leading to altered trafficking of CD8+ T cells to these tissues [59] . At this end, early initiation of ART ameliorates fibrosis and maintains the T lymphocyte balance in blood [60] .
Cytokines mediate na€ ıve and memory CD8+ T-cell survival and proliferation
Acute HIV-1 infection leads to disturbances in the production of a range of cytokines which in many different contexts have been implicated in HIV-1 replication, immune activation and disease progression.
Cytokines are important players in regulating the expansion and maintenance of naive, memory and effector CD8+ T cells. Particularly, the role of common c chain cytokines, including IL-2, IL-7, IL-15 and IL-4, in T-cell homoeostasis has been extensively studied. Amongst cytokines belonging to the common c chain family, IL-7 and IL-15 are the major regulators of naive and memory T-cell homoeostasis, with CD8+ T cells being more responsive to the effects of cytokines under lymphopenia, compared to CD4+ T cells [61] . IL-7 maintains naive CD4+ and CD8+ T-cell survival in vivo and is responsible for T-cell proliferation under lymphopenic conditions [62, 63] . Both naive and memory CD8+ T cells express high levels of the IL7Ra and overexpression of IL-7 in transgenic mice results in an increased number of CD8+ T cells without measurable increased proliferation [64, 65] ; according to these findings, IL-7 does not regulate the turnover of memory CD8+ T cells under homoeostasis but rather maintains the survival of these cells. However, in conditions of T-cell lymphopenia, IL-7 is needed for proliferation of memory T cells [61, 66] (Fig. 3a) .
Interestingly, during HIV-1 infection, lymphopenia and loss of CD4+ T cells are associated with increased IL-7 concentration in circulation [67] ; even though IL-7 concentration declines in patients after long-term ART, IL-7 levels still remain above physiological levels [68, 69] . Administration of recombinant IL-7 to HIV-1-infected patients led to an increased number of memory CD4+ and CD8+ T cells [70] . These findings, taken together, indicate that IL-7 can play a role in CD8+ T-cell survival and therefore contribute to the increased CD8+ T-cell counts observed during HIV-1 infection.
Under homoeostatic conditions, memory CD8+ T cells undergo low, but continuous proliferation [71] with IL-15 being a major regulator of this process [72] (Fig. 3b) . Memory CD8+ T cells express higher levels of the shared CD122 and IL-15Ra chains, which are parts of the IL-15 receptor, compared to their naive counterparts [73, 74] . In addition, blockage of CD122 leads to inhibition of memory CD8+ T-cell proliferation [75] . Interestingly, under inflammatory conditions, a different role for IL-15 has been described. Production of IL-15 in response to virus-induced type I IFNs leads to memory CD8+ T-cell proliferation independently of antigen re-encounter [76] (Fig. 3c) . Furthermore, IL-15, together with IL-2, can induce proliferation of naive CD8+ T cells under lymphopenia [77] , and mice lacking IL-15R have profound defects in differentiation of CD8+ T cells [78] (Fig. 3a) . Primary antiviral CD8+ T-cell responses were shown to be dependent on the presence of IL-15 in vivo in mice [74] . IL-15 was shown to upregulate the migration of memory CD8+ T cells to inflamed tissues (Fig. 2) in an antigen-independent manner, whereas for trafficking and migration of naive CD8+ T cells, TCR engagement is necessary [79] .
During chronic HIV-1 infection, although only a small percentage of CD8+ T cells have specificities for HIV-1 antigens, the majority of CD8+ T cells exhibit an activated phenotype [17, 80] suggesting that CD8+ T-cell proliferation is mediated through bystander mechanisms. IL-15 expression was recently shown to be increased in the LNs of untreated HIV-1-infected individuals, potentially leading to expansion of memory CD8+ T cells with a range of specificities; interestingly, a direct correlation was observed between IL-15 levels in the LNs with the number of CD8+ T cells in blood [81] . IL-15 concentration was also found to be increased in the blood of HIV-1 viremic individuals and to correlate with markers of inflammation including sCD14 [82] , released from activated macrophages. IL-15 can be produced by a number of different cell types including dendritic cells and monocytes upon activation [83, 84] , as well as by stromal cells in the lymphoid tissue, and its production can be enhanced upon specific conditions, as age or activation signals [85] (Fig. 4) .
Different microbial factors, including LPS, are released after fenestration of the intestinal epithelial barrier already at early stages of HIV-1 infection [86] , and this process is not completely reverted by early ART initiation [87] . The release of microbial products can lead to increased cell activation and IL-15 production by a plethora of both immune and nonimmune cells (Fig. 4) infection, a higher CD4+/CD8+ T-cell ratio and reduced immune activation can be found as compared to patients initiating ART during the chronic phase of infection [88, 89] ; according to these findings it is likely that the magnitude of immune activation leading to IL-15 production by the cells mentioned above, the time frame of IL-15 production and the length of CD8+ T-cell exposure to IL-15 may be some of the factors regulating CD8+ Tcell expansion.
Inflammatory cytokines may contribute to expansion of the CD8+ T-cell pool during HIV-1 infection
In addition to the common c chain cytokines, the inflammatory cytokines IL-12, IL1b, IL-18 and type I IFNs also regulate memory T-cell homoeostasis [90] [91] [92] [93] (Fig. 4) . Interestingly, the differentiation of antigen-specific memory CD8+ T cells during antigen encounter is enhanced by the presence of inflammatory cytokines [94] . IFNa is expressed at higher levels in PBMCs and lymphoid tissue from HIV-1-infected individuals compared to healthy controls [95, 96] . IL-2 was shown to induce expansion of na€ ıve CD8+ T cells during lymphopenic conditions (Fig. 3a) [77] and to inhibit excessive memory CD8+ T-cell proliferation induced by IL-15 [75] (Fig. 3b) .
Plasmacytoid dendritic cells (pDCs) are the major producers of type I IFNs upon TLR activation; microbial translocation during HIV-1 infection provides the ligands necessary for the production of high levels of type I IFNs by pDCs [97] (Fig. 4) .
As type I IFNs were shown to be required for expansion of CD8+ T cells during infection [98] , and type I IFNs can in addition regulate IL-15 production [76] , a role for their involvement in expansion and persistence of elevated numbers of CD8+ T cells during HIV-1 infection cannot be excluded (Fig. 4) . IL-12 can also increase the expansion of na€ ıve CD8+ T cells [99] , and it was shown that IL-12-deficient mice have more memory CD8+ T cells after infection with L. mocytogenes [90] . IL-1b can also induce expansion of both CD4+ and CD8+ T cells [100] (Fig. 4) . Interestingly, IL-12 concentration is increased at early stages of SIV infection in plasma of infected rhesus macaques, whilst IL-1b is expressed at higher levels compared to controls in LN from HIV-1-infected individuals even after ART [100] . These data indicate that, even though inflammatory cytokines were shown to have beneficiary effects in antiviral responses, the consistent inflammation and presence of these cytokines during HIV-1 infection may contribute to the deregulated expansion of CD8+ T cells. tissues and in proliferation of HIV-1 specific as well as nonantigen-specific CD8+ T-cell clones.
The magnitude of inflammation and immune activation during HIV-1 infection could influence the homing capacities of CD8+ T cells as well as their retention in inflamed and lymphoid tissues. It is likely that a pool of activated CD8+ T cells with the capacity to migrate to inflamed tissues is generated in response to infection; these cells may be retained at the sites of inflammation and maintained within these tissues through a slow proliferation rate which may occur even in the absence of antigen. Subsequently, CD8+ T cells may return into circulation at different rates depending on the viral load and the degree of inflammation, which can be influenced by the time between initial infection and ART administration, accounting for the inverted CD4+/CD8+ T-cell ratio noticed during HIV-1 infection.
Even though in many infections, the pattern of migration of CD4+ and CD8+ T cells is considered comparable, it is interesting that in herpes simplex virus infection, different patterns of homing capacity to and within inflamed tissue and blood have been reported for memory CD4+ and CD8+ T cells [101] . These observations may help explaining the persistence of a high number of CD8+ T cells in blood of HIV-1-infected patients even after normalization of CD4+ T-cell counts that take place following ART administration; it is possible that, during HIV-1 infection, normalization of homing properties occurs at differential speed for CD4+ T and CD8+ T cells, due to intrinsic differences between the two cell types.
ART is inadequate in normalizing CD8+ T-cell number unless initiated during primary HIV-1 infection [4] ; features of immune senescence, however, persists suggesting that the properties of CD8+T cells may not be adequate to kill HIV-1 infected cells even when ART is provided in the early phase of infection [89, 102] . New therapy strategies targeting specific biological pathways uniquely involved in the regulation of CD8+ T-cell functions, in combination with ART, could lead to normalization of CD8+ T-cell numbers in patients with HIV-1 and subsequent reductions in the overall disease burden.
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